Foghorn Therapeutics Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
FHTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Technology Square, Suite 700, Cambridge, MA

Insiders trading volume in the past year

Foghorn Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cigall Kadoch Director $29.9M Aug 31, 2022
Flagship Pioneering Inc. 10%+ Owner $20M +$20M May 22, 2024
Adrian Gottschalk Chief Executive Officer, Director $5.14M Jan 24, 2024
Carl Decicco Chief Scientific Officer $3.1M Dec 9, 2021
Kristian Humer Chief Financial Officer $1.66M Apr 16, 2024
Anna Rivkin Chief Business Officer $1.49M Sep 3, 2024
Steven F. Bellon Chief Scientific Officer $1.31M -$190K -12.7% Sep 9, 2024
Fanny Cavalie Chief Strategy/Bus Ops Officer $1.05M -$72.1K -6.41% Jun 21, 2024
Allan Reine Chief Financial Officer $719K Jan 16, 2024
Michael LaCascia Chief Legal Officer $306K Jan 24, 2024
Carlos Costa Chief People Officer $220K -$591K -72.9% Sep 20, 2024
Samuel Agresta Chief Medical Officer $184K Sep 11, 2023
Alfonso Quintas Cardama Chief Medical Officer $184K Jan 24, 2024
Douglas G. Cole Director $88.3K Jun 26, 2024
Simba Gill Director $88.3K Jun 26, 2024
B. Lynne Parshall Director $88.3K Jun 26, 2024
Ian F. Smith Director $88.3K Jun 26, 2024
Michael Mendelsohn Director $88.3K Jun 26, 2024
Thomas J. Lynch Jr. Director $88.3K Jun 26, 2024
Adam Koppel Director $88.3K Jun 26, 2024
Scott Biller Director $88.3K Jun 26, 2024
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner May 22, 2024

Recent Insider Transactions by Companies or Individuals for Foghorn Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.